Sign in
CompletedPhase 1

A trial of prednisolone in combination with SPI-62 in participants with polymyalgia rheumatica (PMR)

Key facts

Who runs it
Sparrow Pharmaceuticals Inc.
Where
Germany5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 1
People taking part
14 people enrolled
Started
11 Mar 2024
Ended
3 Dec 2024
Type of study
Interventional
Record updated
19 April 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
19 April 2024